Ropporin-1 and 1B Are Widely Expressed in Human Melanoma and Evoke Strong Humoral Immune Responses

SIMPLE SUMMARY: Despite the unprecedented clinical benefit of immunotherapy in melanoma, some patients still do not respond to treatment, arguing the need for novel therapeutic targets. The aim of this study was to investigate the therapeutic potential of two understudied proteins, Ropporin-1 (ROPN1...

Descripción completa

Detalles Bibliográficos
Autores principales: Da Gama Duarte, Jessica, Woods, Katherine, Quigley, Luke T., Deceneux, Cyril, Tutuka, Candani, Witkowski, Tom, Ostrouska, Simone, Hudson, Chris, Tsao, Simon Chang-Hao, Pasam, Anupama, Dobrovic, Alexander, Blackburn, Jonathan M., Cebon, Jonathan, Behren, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069442/
https://www.ncbi.nlm.nih.gov/pubmed/33918976
http://dx.doi.org/10.3390/cancers13081805

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069442/
https://www.ncbi.nlm.nih.gov/pubmed/33918976
http://dx.doi.org/10.3390/cancers13081805

Ejemplares similares